Breast cancer related lymphoedema (BRCL) is an under-recognised health condition that occurs in 20% of women after receiving breast cancer treatment. BRCL can affect a patient's physical and mental health and is costly to the NHS. In this blog, James Moore, a biomedical engineering researcher at Imperial College, talks about how he has involved patients in designing an innovative solution to this issue.